<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JCT</journal-id><journal-title-group><journal-title>Journal of Cancer Therapy</journal-title></journal-title-group><issn pub-type="epub">2151-1934</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jct.2019.108052</article-id><article-id pub-id-type="publisher-id">JCT-94170</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Analysis of the Onco-Vascular Approach in Retroperitoneal Sarcoma with Vascular Involvement
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zeiad</surname><given-names>Gad</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ahmed</surname><given-names>Gamal</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Karim</surname><given-names>Sallam</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Vascular Surgery Department, Faculty of Medicine, Cairo University, Cairo, Egypt</addr-line></aff><aff id="aff1"><addr-line>Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt</addr-line></aff><pub-date pub-type="epub"><day>31</day><month>07</month><year>2019</year></pub-date><volume>10</volume><issue>08</issue><fpage>632</fpage><lpage>641</lpage><history><date date-type="received"><day>6,</day>	<month>July</month>	<year>2018</year></date><date date-type="rev-recd"><day>4,</day>	<month>August</month>	<year>2019</year>	</date><date date-type="accepted"><day>7,</day>	<month>August</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background:
   Due to the limited number of clinical series and the lack of multi-institutional or national registries concerning retroperitoneal sarcoma (RPS) extending to major arterio-venous structures, the short and long-term benefits following concomitant resection of these major structures are still antagonistic. <b>Objective:</b> To present our institutional experience with RPS tumors, to assess their vascular involvement and to analyze the outcomes of onco-vascular approach. <b>Patients and methods:</b> A retrospective review of our institutional RPS patients’ clinical charts was performed. All consecutive adult patients surgically treated for RPS were included<b>.</b> Resection of RPS tumors was followed by histopathological examination for grading. Types of vascular involvement were assessed preoperatively. RPS tumors were resected en bloc together with blood vessels according to the type of vascular involvement and the surgical standards. <b>Results:</b> This study included 14 patients; 8 males (57%) and 6 females (43%) with RPS. Vascular resection was performed in all patients. Adherent structures were resected in 43%. Resection was performed for 29% RPSs with arterial venous involvement, 14% with only arterial involvement, and 57% with only venous involvement. All RPSs were classified as high-grade lesions, and 64% showed secondarily major vessels involvement. 43% of patients were treated by arterial resection. 80% had venous involvement. Venous resections were followed by venous reconstruction in all patients with both arterial and venous involvement. The morbidity rate was 43% while the mortality rate was 7%. <b>Conclusion:</b> Complete resection with clear margins is important for long-term survival in patients with retroperitoneal soft tissue sarcomas.
 
</p></abstract><kwd-group><kwd>Outcomes</kwd><kwd> Retroperitoneal Sarcoma</kwd><kwd> Vascular Approach</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Retroperitoneal sarcomas (RPS) that arise from mesenchymal cells account for about 15% of soft tissue sarcomas [<xref ref-type="bibr" rid="scirp.94170-ref1">1</xref>] . Little is known about the biological behavior of the tumor, and no specific etiological associations have been identified [<xref ref-type="bibr" rid="scirp.94170-ref2">2</xref>] . Such tumors are usually large at initial presentation mounting no obvious clinical symptoms [<xref ref-type="bibr" rid="scirp.94170-ref3">3</xref>] . The management of the disease remains a challenge [<xref ref-type="bibr" rid="scirp.94170-ref4">4</xref>] and surgical resection of localized RPS aiming for gross or microscopically negative margins is still the best [<xref ref-type="bibr" rid="scirp.94170-ref5">5</xref>] . However, because of the high rate of local recurrence, the prognosis of the patients with RPS is generally poor [<xref ref-type="bibr" rid="scirp.94170-ref2">2</xref>] . Local recurrence accounts for 77% of RPS-related deaths without concomitant metastasis, it is, therefore, important to control the disease locally [<xref ref-type="bibr" rid="scirp.94170-ref6">6</xref>] . It is common for RPS to involve major arterio-venous structures [<xref ref-type="bibr" rid="scirp.94170-ref7">7</xref>] . Planned vascular resection is essential to achieve the oncologic standards of complete tumor resection with microscopically negative margins and the prevention of tumor spillage during surgery [<xref ref-type="bibr" rid="scirp.94170-ref8">8</xref>] . Still, limited knowledge is available on the extent of surgical resection and the best surgical approach [<xref ref-type="bibr" rid="scirp.94170-ref9">9</xref>] . Three major factors influence the need and the type of vascular replacement: the site of the lesion and especially the relation to renal veins; the extent of IVC involvement (partial or circumferential); and the presence of well-established collateral venous system [<xref ref-type="bibr" rid="scirp.94170-ref9">9</xref>] . RPS tumors extending to major arterio-venous structures might be rare. Due to the limited number of clinical series and the lack of multi-institutional or national registries, the short and long-term benefits following concomitant resection of major arterio-venous structures are still antagonistic [<xref ref-type="bibr" rid="scirp.94170-ref9">9</xref>] .</p><p>Our aim in this work was to present our institutional experience with RPS tumors, assess their vascular involvement and to analyze the outcomes (Short and long-term) of onco-vascular approach.</p></sec><sec id="s2"><title>2. Patients and Methods</title><sec id="s2_1"><title>2.1. Inclusion Criteria</title><p>All adult patients consecutively diagnosed with RPS and treated at the National Cancer Institute (NCI), Cairo University-Department of Surgical Oncology from 2004 to 2010 (n = 14). The primary disease involved major arterio-venous structures and hence an onco-vascular approach was followed. RPS tumors were imaged using ultrasonography (US), magnetic resonance imaging (MRI), computed tomography (CT), or a combination of the three with or without angiography. The indications for RPS resection en bloc together with major blood vessels were applied in patients with clear involvement of major blood vessels. Such an involvement was established when MRI or CT scans did not show a rim of normal tissue in-between the tumor and the vessel. Resection of RPS tumors was followed by histopathological examination. A dedicated pathologist assessed the resected specimens and finally commented on the grade guided by the degree of cellularity, differentiation, pleomorphism, necrosis and mitotic activity, and categorized them into low-grade, intermediate-grade, and high-grade RPS [<xref ref-type="bibr" rid="scirp.94170-ref10">10</xref>] . Exclusion criteria: suprarenal vessels involvement by tumor.</p></sec><sec id="s2_2"><title>2.2. Classification of Vascular Involvement</title><p>Types of vascular involvement were assessed preoperatively by high-resolution CT scans or MRI. Primary and secondary vessel involvements are indistinguishable by preoperative radiologic tomography or by clinical assessment. Therefore, both primary and secondary blood vessel involvement were classified as follows: type I, RPS involving major arteries and veins; type II, RPS affecting only arterial blood vessels; type III, RPS involving the veins without altering an artery; type IV, RPS without direct involvement of arterial or venous blood vessels [<xref ref-type="bibr" rid="scirp.94170-ref9">9</xref>] .</p></sec><sec id="s2_3"><title>2.3. Surgery, Radiation, and Vascular Replacement</title><p>RPS tumors were resected en bloc together with blood vessels according to the type of vascular involvement and the surgical standards [<xref ref-type="bibr" rid="scirp.94170-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref11">11</xref>] . Radiotherapy was given in higher-grade and recurrent STSs with sparing of radiosensitive structures such as ureter or small bowel from intraoperative radiation by dissection, mobilization, and positioning [<xref ref-type="bibr" rid="scirp.94170-ref12">12</xref>] .</p><p>Blood flow was restored with respect to the resection site and the extent of the vascular defect and collateral blood flow (e.g., venous drainage). Arterial reconstructions were usually performed by the appropriate method, such as primary anastomosis, reinsertion, or synthetic prostheses (expanded polytetrafluoroethylene [ePTFE] or Dacron), preferably in an anatomic position. Autologous vein (reversed great saphenous vein) was considered in selective cases (visceral or iliac arteries). Circular venous defects of the IVC were reconstructed by ePTFE prostheses when a primary anastomosis was impossible. For localized defects of the IVC, either a synthetic or a venous patch was used or venoplasty (longitudinal suture) was performed. Veins occluded by thrombosis were not reconstructed (ligation of the proximal and distal venous stump).</p><p>Patients routinely received prophylactic antibiotic treatment (cephalosporin) both preoperatively and postoperatively. Bowel preparations were not routinely administered. Perioperatively, a low-dose regimen of heparin was administered (unfractionated heparin intraoperatively and low-molecular-weight heparin in the postoperative phase). After discharge, oral anticoagulants were not routinely administered.</p></sec><sec id="s2_4"><title>2.4. Follow-Up</title><p>Patients were seen regularly during the observation period at our outpatient clinic. The standard follow-up was weekly for one month, then monthly for the first 3 months, then every 3 months for a year, followed by a visit every 6 months for 2 years. Patients were assessed clinically following a CT imaging organized beforehand to evaluate the patency of arterial and venous reconstructions.</p></sec></sec><sec id="s3"><title>3. Results</title><p>A retrospective review of our institutional retroperitoneal sarcoma database and patients’ clinical charts was performed. All consecutive adult patients surgically treated at our NCI from 2004 to 2010 for primary RPS directly arising from or secondarily involved blood vessels were included. This study included 14 patients; 8 males (57%) and 6 females (43%), their age ranged from 29 - 68 years with median age 51 years. The size of the tumor ranged from 5 - 15 cm with median size of 5 cm in diameter.</p><sec id="s3_1"><title>3.1. Respectability and Vascular Infiltration</title><p>Vascular resection was performed in all 14 patients. Adherent organs or structures were resected in 43% of patients (n = 6); kidney (n = 4), large bowel (n = 1), and small bowel (n = 1) were the resected organs.</p><p>Resection was performed for four (29%) RPSs with arterial venous involvement (type I), 2 (14%) with only arterial involvement (type II), and eight (57%) with only venous involvement (type III). Histopathologic examination of the specimens showed that five (36%) RPSs originated in the blood vessel wall, including four leiomyosarcomas of the inferior vena cava and one angiosarcoma of the aortic wall (infrarenal segment) (<xref ref-type="table" rid="table1">Table 1</xref>). All these RPSs were classified as high-grade lesions, and nine (64%) secondarily involved major vessels. Of these nine RPSs infiltrating the vessel wall (44.4%, n = 4/9 showed both arterial and venous infiltration, 44.4%, n = 4/9 with venous infiltration only, and 11.2%, n = 1/9 with arterial infiltration only).</p><p>Diverse histologic subtypes (e.g., liposarcoma, malignant fibrous histiocytoma, and clear cell sarcoma) and either primary disease (66.7% n = 6/9) or locally recurring tumors (33.3%, n = 3) were diagnosed for secondary vascular involvement. Tumor growth also affected adjacent retroperitoneal or visceral organs. Of six patients in whom organs were resected, 66.7% (n = 4/6) presented with organ infiltration on histopathologic examination: kidney (75%, n = 3/4); and small bowel (25%, n = 1).</p></sec><sec id="s3_2"><title>3.2. Morbidity and Mortality</title><p>Morbidity was observed in 43% (n = 6) of patients. Infection of the graft (14%, n = 2)</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Results of histopathologic evaluation of the surgical specimen concerning vascular and organ involvement in 14 patients with retroperitoneal soft tissue sarcomas</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Characteristics</th><th align="center" valign="middle" >Number (14)</th><th align="center" valign="middle" >Rate (%)</th></tr></thead><tr><td align="center" valign="middle" >Primary involvement Inferior vena cava Aorta (infrarenal segment)</td><td align="center" valign="middle" >5 4 1</td><td align="center" valign="middle" >36 29 7</td></tr><tr><td align="center" valign="middle" >Secondary involvement (vascular infiltration) Inferior vena cava and aorta (type I) Right common iliac artery (type II) Inferior vena cava (type III) Superior mesenteric vein (type III) Right and left common iliac bifurcation vein (type III)</td><td align="center" valign="middle" >9 4 1 1 1 2</td><td align="center" valign="middle" >64 29 7 7 7 14</td></tr></tbody></table></table-wrap><p>was the most common complication. Patients with wound infections were successfully treated conservatively by IV antibiotics. One patient had intraoperative bleeding that had been controlled by blood transfusion. Pulmonary embolism was observed in one patient and had been properly managed. A thromboembolic complication treated by blood vessel reconstruction was observed in one patient. Abdominal wall dehiscence was observed in one patient.</p><p>The mortality rate was 7% owing to the death of one patient on the first postoperative day from massive intraoperative blood loss with subsequent multiorgan failure.</p></sec><sec id="s3_3"><title>3.3. Arterial Resection and Graft Function</title><p>43% of the 14 patients (n = 6) were treated by arterial resection. Four arterial resections (29%) were performed for RPSs that involved both arteries and veins (type I), and two arterial resections (14%) were for tumors that only involved arteries (type II). All arterial resections were followed by vessel reconstruction. In 83% of the six reconstructions (n = 5), synthetic grafts were used, and one reimplantation of the celiac trunk was done.</p><p>No patient was lost to follow-up. Median follow-up was 19 months for surviving patients. The overall patency rate of arterial reconstructions was 83% (5 of 6 reconstructions).</p></sec><sec id="s3_4"><title>3.4. Venous Resection and Graft Function</title><p>80% of patients (n = 12) had venous involvement: four with arterial involvement also (type I RPS) and eight with only venous involvement (type III). Venous resections were followed by venous reconstruction in all patients with both arterial and venous involvement. Resections were reconstructed in 88% of the patients (n = 7) with venous involvement alone. In one patient, the vessels could not be reconstructed because of scarring in the operation field.</p></sec><sec id="s3_5"><title>3.5. Tumor Control and Survival</title><p>After complete tumor resection, 21% of patients (n = 3) presented with local recurrences. One patient was from the type II group (Aorta involvement) and had the recurrence within 1 year; the other two patients were from the type I (both arterial &amp; venous involvement) and had the recurrence within 2 years. At the last follow-up (2 years), 7 patients (50%) were alive.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>Surgical risks were high, and the long-term prognosis is usually poor when there is involvement of major blood vessels in tumor making a limiting factor for curative surgery [<xref ref-type="bibr" rid="scirp.94170-ref13">13</xref>] . Advances in surgical techniques have allowed extending the limits of surgery beyond major vascular resection, with a relatively low rate of postoperative complications [<xref ref-type="bibr" rid="scirp.94170-ref14">14</xref>] .</p><p>The number of patients with retroperitoneal STSs requiring major vascular resections is unknown [<xref ref-type="bibr" rid="scirp.94170-ref9">9</xref>] . Leiomyosarcomas, liposarcomas, and other types of sarcomas were associated with vascular involvement [<xref ref-type="bibr" rid="scirp.94170-ref15">15</xref>] . Most studies focus selectively on the very rare entity of primary leiomyosarcoma of the vena cava, neglecting all other sarcomas that involve blood vessels in the retroperitoneum [<xref ref-type="bibr" rid="scirp.94170-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref20">20</xref>] . Most of the STSs secondarily involved vascular structures either by histologically proven vascular infiltration or by vascular encasement [<xref ref-type="bibr" rid="scirp.94170-ref9">9</xref>] .</p><p>Retroperitoneal sarcomas are usually large at diagnosis, and the differentiation between primary or secondary blood vessel involvements is not made before the pathologist examines the specimen [<xref ref-type="bibr" rid="scirp.94170-ref10">10</xref>] . This implicates that both have to be treated by a common procedural algorithm and resection strategy [<xref ref-type="bibr" rid="scirp.94170-ref20">20</xref>] . Schwarzbach suggested a four-stage classification that describes the pattern of vascular involvement by retroperitoneal STSs [<xref ref-type="bibr" rid="scirp.94170-ref9">9</xref>] . In the current study, the most common type of vascular involvement was type III, venous involvement (57%). This was in agreement by a large number of reports about leiomyosarcomas of the inferior vena cava [<xref ref-type="bibr" rid="scirp.94170-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref20">20</xref>] . In type III tumors, surgery is performed on the vena cava or iliac veins [<xref ref-type="bibr" rid="scirp.94170-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref20">20</xref>] .</p><p>The present study also shows that the simultaneous involvement of retroperitoneal arteries and veins by type I sarcomas occurred with a lower frequency (29%). Dzsinich et al., [<xref ref-type="bibr" rid="scirp.94170-ref16">16</xref>] reported 7.7% prevalence of both arterial and venous involvement in 13 cases with leiomyosarcomas. Less common, in this study, is isolated arterial involvement by retroperitoneal sarcomas (type II) (14%). Chiche et al., [<xref ref-type="bibr" rid="scirp.94170-ref21">21</xref>] reported five patients with sole arterial growth pattern. Type II sarcomas usually require vascular reconstruction [<xref ref-type="bibr" rid="scirp.94170-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref21">21</xref>] .</p><p>The decision of whether to resect blood vessels depends especially on preoperative radiologic imaging results [<xref ref-type="bibr" rid="scirp.94170-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref11">11</xref>] . angiography or contrast-enhanced MRI can be used as diagnostic procedure [<xref ref-type="bibr" rid="scirp.94170-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref22">22</xref>] . In patients with palpable pulses, routine angiography or MR angiography is not necessary, and venography is usually not required [<xref ref-type="bibr" rid="scirp.94170-ref22">22</xref>] . Intravascular ultrasound scans can be used as a complementary diagnostic tool. The value of positron emission tomography is still unclear [<xref ref-type="bibr" rid="scirp.94170-ref23">23</xref>] .</p><p>Arterial replacement was usually accomplished by implanting a synthetic vascular prosthesis in anatomic position. Visceral arteries must be resected for tumors extending into the mesenteric root. In such cases, reconstruction can necessitate primary anastomosis, reinsertion, or bridging by small-diameter grafts (e.g., great saphenous vein, synthetic 6-mm ePTFE, or Dacron prostheses). Good long-term patency rates (83%) were observed in this study when preferably synthetic grafts were used for arterial reconstructions. Arterial bypass grafting after sarcoma surgery has been recognized in the literature in few series [<xref ref-type="bibr" rid="scirp.94170-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref24">24</xref>] .</p><p>Central venous repair after resection prevents lower limb edema and the clinical sequelae such as pain, swelling, tension, and skin alterations [<xref ref-type="bibr" rid="scirp.94170-ref25">25</xref>] . Expanded PTFE tube prostheses or ePTFE patches are preferred for reconstruction of the inferior and middle portion of the vena cava. Only in case of pre-existing venous thrombosis should caval ligation be done below the renal veins or in the iliac veins. Retroperitoneal venous reconstructions after STS resection have been previously reported [<xref ref-type="bibr" rid="scirp.94170-ref16">16</xref>] - [<xref ref-type="bibr" rid="scirp.94170-ref21">21</xref>] .</p><p>The morbidity and reoperation rates in our study were acceptable and thus favor the concept of vascular resection with consecutive repair. As bleeding was the most common complication in some series [<xref ref-type="bibr" rid="scirp.94170-ref9">9</xref>] ; careful hemostasis and cautious intraoperative administration of heparin have been suggested [<xref ref-type="bibr" rid="scirp.94170-ref9">9</xref>] .</p><p>According to our institutional surgical policy, 43% of patients received multi-visceral resection to improve quality of margins and subsequently local control [<xref ref-type="bibr" rid="scirp.94170-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref27">27</xref>] .</p><p>One of the most common complications in venous reconstruction is graft occlusion, ranging between 7% and 28% [<xref ref-type="bibr" rid="scirp.94170-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref28">28</xref>] . The most used reported graft is PTFE: it is claimed to be more resistant to abdominal viscera compression and consequently less prone to thrombosis [<xref ref-type="bibr" rid="scirp.94170-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref28">28</xref>] . The venous graft is preferable for its theoretical superiority against infection. Whenever a banked homograft of adequate size is available, anatomic restoration of IVC integrity and size matching are more easily achievable than with autologous venous graft (surgical technique).</p><p>Bood vessel resection should be considered feasible whenever necessary in RSTS. This is of high importance; especially that completeness of surgical resection is the predominant prognosticator in RSTS [<xref ref-type="bibr" rid="scirp.94170-ref29">29</xref>] .</p><p>Some authors reported the prognosis of patients who undergo complete resection of retroperitoneal sarcoma with major vascular resection to be very poor, with no long-term survivors [<xref ref-type="bibr" rid="scirp.94170-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref30">30</xref>] [<xref ref-type="bibr" rid="scirp.94170-ref31">31</xref>] . Indeed this bad outcome may be possibly related to disease extent of the patients reported in those series, as indirectly reflected by the need to perform vascular resection, rather than to the procedure itself [<xref ref-type="bibr" rid="scirp.94170-ref32">32</xref>] .</p></sec><sec id="s5"><title>5. Conclusion</title><p>This study shows that complete resection with clear margins is important for long-term survival in patients with retroperitoneal soft tissue sarcomas. Primary sarcomas or local recurrences, as well as tumors with primary vascular involvement or secondary vascular involvement, require resection of diseased blood vessels necessary to improve the completeness of tumor clearance. The extent of vascular resection and the appropriate vascular repair has to be assessed in the individual patient according to the preoperative imaging, intraoperative findings, and extent of resection, and it should be carefully planned on the basis of the stage of the disease. The proposed classification and treatment algorithm can be used to plan resection and vascular replacement.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Gad, Z., Gamal, A. and Sallam, K. (2019) Analysis of the Onco-Vascular Approach in Retroperitoneal Sarcoma with Vascular Involvement. Journal of Cancer Therapy, 10, 632-641. https://doi.org/10.4236/jct.2019.108052</p></sec></body><back><ref-list><title>References</title><ref id="scirp.94170-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Windham, T.C. and Pisters, P.W. (2005) Retroperitoneal Sarcomas. Cancer Control, 12, 36-43. https://doi.org/10.1177/107327480501200105</mixed-citation></ref><ref id="scirp.94170-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Chen, C.Q., Yin, L., Peng, C.H., Cai, Y., Li, Y.F., Zhao, R., Zhou, H.J. and Li, H.W. (2007) Prognostic Factors of Retroperitoneal Soft Tissue Sarcomas: Analysis of 132 Cases. Chinese Medical Journal, 120, 1047-1050.  
https://doi.org/10.1097/00029330-200706020-00004</mixed-citation></ref><ref id="scirp.94170-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Burke, A.P. and Virmani, R. (1993) Sarcomas of the Great Vessels: A Clinicopathologic Study. Cancer, 71, 1761-1773.  
https://doi.org/10.1002/1097-0142(19930301)71:5&lt;1761::AID-CNCR2820710510&gt;3.0.CO;2-7</mixed-citation></ref><ref id="scirp.94170-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Hassan, I., Park, S.Z., Donohue, J.H., Nagorney, D.M., Kay, P.A., Nasciemento, A.G., et al. (2004) Operative Management of Primary Retroperitoneal Sarcomas a Reappraisal of an Institutional Experience. Annals of Surgery, 239, 44-50.  
https://doi.org/10.1097/01.sla.0000108670.31446.54</mixed-citation></ref><ref id="scirp.94170-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Raut, C.P. and Pisters, P.W. (2006) Retroperitoneal Sarcomas: Combined Modality Treatment Approaches. Journal of Surgical Oncology, 94, 81-87.  
https://doi.org/10.1002/jso.20543</mixed-citation></ref><ref id="scirp.94170-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Stojadinovic, A., Yeh, A. and Brennan, M.F. (2002) Completely Resected Recurrent Soft Tissue Sarcoma: Primary Anatomic Site Governs Outcome. Journal of the American College of Surgeons, 194, 436-447.  
https://doi.org/10.1016/S1072-7515(02)01120-1</mixed-citation></ref><ref id="scirp.94170-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Zheng, W., Song, S. and Liang, F. (1998) Major Blood Vessel Excision and Reconstruction in the Treatment of Retroperitoneal Neoplasms. Chinese Journal of Oncology, 20, 225-227.</mixed-citation></ref><ref id="scirp.94170-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Karakousis, C.P., Kontzoglou, K. and Driscoll, D.L. (1995) Resectability of Retroperitoneal Sarcomas: A Matter of Surgical Techniques. European Journal of Surgical Oncology, 21, 617-622. https://doi.org/10.1016/S0748-7983(95)95305-1</mixed-citation></ref><ref id="scirp.94170-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Schwarzbach, M.H., Hormann, Y., Hinz, U., Leowardi, C., Bockler, D., Mechtersheimer, G., Friess, H., Büchler, M.W. and Allenberg, J.R. (2006) Clinical Results of Surgery for Retroperitoneal Sarcoma with Major Blood Vessel Involvement. Journal of Vascular Surgery, 44, 46-55.  
https://doi.org/10.1016/j.jvs.2006.03.001</mixed-citation></ref><ref id="scirp.94170-ref10"><label>10</label><mixed-citation publication-type="book" xlink:type="simple">Enzinger, F.M. and Weiss, S.W. (1995) Inferior Vena Cava Leiomyosarcoma. In: Enzinger, F.M. and Weiss, S.W., Eds., Soft Tissue Tumors, 3rd Edition, Mosby, St. Louis, 505-506.</mixed-citation></ref><ref id="scirp.94170-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Schwarzbach, M.H.M., Hormann, Y., Hinz, U., Bernd, L., Willeke, F., Mechtersheimer, G., et al. (2005) Results of Limb-Sparing Surgery with Vascular Replacement for Soft Tissue Sarcoma in the Lower Extremity. Journal of Vascular Surgery, 42, 88-96. https://doi.org/10.1016/j.jvs.2005.03.017</mixed-citation></ref><ref id="scirp.94170-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Willeke, F., Eble, M.J., Lehnert, T., Schwarzbach, M.H.M., Hinz, U., Wannenmacher, M., et al. (1995) Intraoperative Radiotherapy within the Treatment of Retroperitoneal Soft Tissue Sarcoma. Chirurg, 66, 899-904.</mixed-citation></ref><ref id="scirp.94170-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Bower, T.C., Nagorney, D.M., Cherry, K.J., Toomey, B.J., Hallett, J.W., Panneton, J.M., et al. (2000) Replacement of the Inferior Vena Cava for Malignancy: An Update. Journal of Vascular Surgery, 31, 270-281.  
https://doi.org/10.1016/S0741-5214(00)90158-7</mixed-citation></ref><ref id="scirp.94170-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Bianchi, C., Ballard, J.L., Bergan, J.H. and Killeen, J.D. (1999) Vascular Reconstruction and Major Resection for Malignancy. The Archives of Surgery, 134, 851-855. https://doi.org/10.1001/archsurg.134.8.851</mixed-citation></ref><ref id="scirp.94170-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Leowardi, C., Hinz, U., Hormann, Y., Wente, M.N., Mechtersheimer, G., Willeke, F., et al. (2005) Malignant Vascular Tumors: Clinical Presentation, Surgical Therapy, and Long Term Prognosis. Annals of Surgical Oncology, 12, 1090-1101.  
https://doi.org/10.1245/ASO.2005.09.002</mixed-citation></ref><ref id="scirp.94170-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Dzsinich, C., Gloviczki, P. and Van Heerden, J.A. (1992) Primary Venous Leiomyosarcoma: A Rare but Lethal Disease. Journal of Vascular Surgery, 15, 592-603. https://doi.org/10.1016/0741-5214(92)90003-Q</mixed-citation></ref><ref id="scirp.94170-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Dong, M., Liang, F. and Song, S. (1998) Resection and Reconstruction of Inferior Vena Cava and Renal Vein in Surgical Treatment of Retroperitoneal Tumors: A Report of 11 Cases. Chinese Journal of Surgery, 36, 23-25.</mixed-citation></ref><ref id="scirp.94170-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Babatasi, G., Massetti, M., Agostini, D., Gallateau, F., Le Page, O., Saloux, E., et al. (1998) Leiomyosarcoma of the Heart and Great Vessels. Annales de Cardiologie et d’Angéiologie, 47, 451-458.</mixed-citation></ref><ref id="scirp.94170-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Ridwelski, K., Rudolph, S., Meyer, F., Buhtz, P., Burger, T. and Lippert, H. (2001) Primary Sarcoma of the Inferior Vena Cava: Review of Diagnosis, Treatment, and Outcomes in a Case Series. International Surgery, 86, 184-190.</mixed-citation></ref><ref id="scirp.94170-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Hollenbeck, S.T., Grobmyer, S.R., Kent, K.C. and Brennan, M.F. (2003) Surgical Treatment and Outcomes of Patients with Primary Inferior Vena Cava Leiomyosarcoma. Journal of the American College of Surgeons, 197, 575-579.  
https://doi.org/10.1016/S1072-7515(03)00433-2</mixed-citation></ref><ref id="scirp.94170-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Chiche, L., Mongredien, B., Brocheriou, I. and Kieffer, E. (2003) Primary Tumors of the Thoracoabdominal Aorta: Surgical Treatment of 5 Patients and Review of the Literature. Annals of Vascular Surgery, 17, 354-364.  
https://doi.org/10.1007/s10016-003-0018-x</mixed-citation></ref><ref id="scirp.94170-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">De Schepper, A.M., De Beuckeleer, L., Vandevenne, J. and Somville, J. (2000) Magnetic Resonance Imaging of Soft Tissue Tumors. European Radiology, 10, 213-223. https://doi.org/10.1007/s003300050037</mixed-citation></ref><ref id="scirp.94170-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Schwarzbach, M.H.M., Hinz, U., Dimitrakopoulou-Strauss, A., Willeke, F., Cardona, S., Mechtersheimer, G., et al. (2005) Prognostic Significance of Preoperative [18-F] Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Imaging in Patients with Resectable Soft Tissue Sarcomas. Annals of Surgery, 241, 286-294. https://doi.org/10.1097/01.sla.0000152663.61348.6f</mixed-citation></ref><ref id="scirp.94170-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Ockert, S., Schumacher, H., Boeckler, D., Schwarzbach, M., Rotert, H. and Allenberg, J.R. (2004) Intraluminal Mass Lesions of the Thoracic Aorta. Chirurg, 11, 41-48.</mixed-citation></ref><ref id="scirp.94170-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Vollmar, J., Loeprecht, H. and Nadjafi, A.S. (1973) Acute Interruption of the Inferior Vena Cava: Ligature or Reconstruction. Münchener Medizinische Wochenschrift, 21, 978-985.</mixed-citation></ref><ref id="scirp.94170-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Bonvalot, S., Miceli, R., Berselli, M., Causeret, S., Colombo, C., Mariani, L., et al. (2010) Aggressive Surgery in Retroperitoneal Soft Tissue Sarcoma Carried out at High-Volume Centers Is Safe and Is Associated with Improved Local Control. Annals of Surgical Oncology, 17, 1507-1514.  
https://doi.org/10.1245/s10434-010-1057-5</mixed-citation></ref><ref id="scirp.94170-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Gronchi, A., Lo Vullo, S., Fiore, M., Mussi, C., Stacchiotti, S., Collini, P., et al. (2009) Aggressive Surgical Policies in a Retrospectively Reviewed Single-Institution Case Series of Retroperitoneal Soft Tissue Sarcoma Patients. Journal of Clinical Oncology, 27, 24-30. https://doi.org/10.1200/JCO.2008.17.8871</mixed-citation></ref><ref id="scirp.94170-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Hardwigsen, J., Baque, P., Crespy, B., Moutardier, V., Delpero, J.R. and Le Treut, Y.P. (2000) Resection of the Inferior Vena Cava for Neoplasms with or without Prosthetic Replacement: A 14-Patient Series. Annals of Surgery, 233, 242-249.  
https://doi.org/10.1097/00000658-200102000-00014</mixed-citation></ref><ref id="scirp.94170-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Lewis, J.J., Leung, D., Woodruff, J.M. and Brennan, M.F. (1998) Retroperitoneal Soft Tissue Sarcoma: Analysis of 500 Patients Treated and Followed at a Single Institution. Annals of Surgery, 228, 355-365.  
https://doi.org/10.1097/00000658-199809000-00008</mixed-citation></ref><ref id="scirp.94170-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Bevilacqua, R.G., Rogatko, A., Hajdu, S.I. and Brennan, M.F. (1991) Prognostic Factors in Primary Retroperitoneal Soft-Tissue Sarcomas. The Archives of Surgery, 126, 328-334. https://doi.org/10.1001/archsurg.1991.01410270072012</mixed-citation></ref><ref id="scirp.94170-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Ito, H., Hornick, J.L.H., Bertagnolli, M.M., George, S., Morgan, J.A., Baldini, E.H., et al. (2007) Leiomyosarcoma of the Inferior Vena Cava: Survival after Aggressive Management. Annals of Surgical Oncology, 14, 3534-3541.  
https://doi.org/10.1245/s10434-007-9552-z</mixed-citation></ref><ref id="scirp.94170-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Fiore, M., Colombo, C., Locati, P., Berselli, M., Radaelli, S., Morosi, C., Casali, P.G. and Gronchi, A. (2012) Surgical Technique, Morbidity, and Outcome of Primary Retroperitoneal Sarcoma Involving Inferior Vena Cava. Annals of Surgical Oncology, 19, 511-518. https://doi.org/10.1245/s10434-011-1954-2</mixed-citation></ref></ref-list></back></article>